These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. On the contribution of group III and IV muscle afferents to the circulatory response to rhythmic exercise in humans. Amann M; Runnels S; Morgan DE; Trinity JD; Fjeldstad AS; Wray DW; Reese VR; Richardson RS J Physiol; 2011 Aug; 589(Pt 15):3855-66. PubMed ID: 21646407 [TBL] [Abstract][Full Text] [Related]
4. Identifying the role of group III/IV muscle afferents in the carotid baroreflex control of mean arterial pressure and heart rate during exercise. Hureau TJ; Weavil JC; Thurston TS; Broxterman RM; Nelson AD; Bledsoe AD; Jessop JE; Richardson RS; Wray DW; Amann M J Physiol; 2018 Apr; 596(8):1373-1384. PubMed ID: 29388218 [TBL] [Abstract][Full Text] [Related]
5. Aging alters muscle reflex control of autonomic cardiovascular responses to rhythmic contractions in humans. Sidhu SK; Weavil JC; Venturelli M; Rossman MJ; Gmelch BS; Bledsoe AD; Richardson RS; Amann M Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1479-89. PubMed ID: 26386110 [TBL] [Abstract][Full Text] [Related]
6. Influence of locomotor muscle group III/IV afferents on cardiovascular and ventilatory responses in human heart failure during submaximal exercise. Smith JR; Joyner MJ; Curry TB; Borlaug BA; Keller-Ross ML; Van Iterson EH; Olson TP J Appl Physiol (1985); 2022 Apr; 132(4):903-914. PubMed ID: 35201931 [TBL] [Abstract][Full Text] [Related]
7. Limb movement-induced hyperemia has a central hemodynamic component: evidence from a neural blockade study. Trinity JD; Amann M; McDaniel J; Fjeldstad AS; Barrett-O'Keefe Z; Runnels S; Morgan DE; Wray DW; Richardson RS Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1693-700. PubMed ID: 20802133 [TBL] [Abstract][Full Text] [Related]
8. The exercise pressor reflex - a pressure-raising mechanism with a limited role in regulating leg perfusion during locomotion in young healthy men. Thurston TS; Weavil JC; Georgescu VP; Wan HY; Birgenheier NM; Morrissey CK; Jessop JE; Amann M J Physiol; 2023 Oct; 601(20):4557-4572. PubMed ID: 37698303 [TBL] [Abstract][Full Text] [Related]
9. Implications of group III and IV muscle afferents for high-intensity endurance exercise performance in humans. Amann M; Blain GM; Proctor LT; Sebranek JJ; Pegelow DF; Dempsey JA J Physiol; 2011 Nov; 589(Pt 21):5299-309. PubMed ID: 21878520 [TBL] [Abstract][Full Text] [Related]
10. Influence of group III/IV muscle afferents on small muscle mass exercise performance: a bioenergetics perspective. Broxterman RM; Hureau TJ; Layec G; Morgan DE; Bledsoe AD; Jessop JE; Amann M; Richardson RS J Physiol; 2018 Jun; 596(12):2301-2314. PubMed ID: 29644702 [TBL] [Abstract][Full Text] [Related]
11. Group III/IV muscle afferents limit the intramuscular metabolic perturbation during whole body exercise in humans. Blain GM; Mangum TS; Sidhu SK; Weavil JC; Hureau TJ; Jessop JE; Bledsoe AD; Richardson RS; Amann M J Physiol; 2016 Sep; 594(18):5303-15. PubMed ID: 27241818 [TBL] [Abstract][Full Text] [Related]
12. Locomotor muscle group III/IV afferents constrain stroke volume and contribute to exercise intolerance in human heart failure. Smith JR; Joyner MJ; Curry TB; Borlaug BA; Keller-Ross ML; Van Iterson EH; Olson TP J Physiol; 2020 Dec; 598(23):5379-5390. PubMed ID: 32886795 [TBL] [Abstract][Full Text] [Related]
13. Spinal μ-opioid receptor-sensitive lower limb muscle afferents determine corticospinal responsiveness and promote central fatigue in upper limb muscle. Sidhu SK; Weavil JC; Venturelli M; Garten RS; Rossman MJ; Richardson RS; Gmelch BS; Morgan DE; Amann M J Physiol; 2014 Nov; 592(22):5011-24. PubMed ID: 25172953 [TBL] [Abstract][Full Text] [Related]
14. Muscle metaboreflex activation increases ventilation and heart rate during dynamic exercise in humans. Lam E; Greenhough E; Nazari P; White MJ; Bruce RM Exp Physiol; 2019 Oct; 104(10):1472-1481. PubMed ID: 31206823 [TBL] [Abstract][Full Text] [Related]
15. Group III and IV muscle afferents contribute to ventilatory and cardiovascular response to rhythmic exercise in humans. Amann M; Blain GM; Proctor LT; Sebranek JJ; Pegelow DF; Dempsey JA J Appl Physiol (1985); 2010 Oct; 109(4):966-76. PubMed ID: 20634355 [TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle signaling and the heart rate and blood pressure response to exercise: insight from heart rate pacing during exercise with a trained and a deconditioned muscle group. Mortensen SP; Svendsen JH; Ersbøll M; Hellsten Y; Secher NH; Saltin B Hypertension; 2013 May; 61(5):1126-33. PubMed ID: 23478101 [TBL] [Abstract][Full Text] [Related]
17. Control of hyperpnoea and pulmonary gas exchange during prolonged exercise: The role of group III/IV muscle afferent feedback. Iannetta D; Weavil JC; Laginestra FG; Thurston TS; Broxterman RM; Jenkinson RH; Curtis MC; Chang J; Wan HY; Amann M J Physiol; 2024 Oct; 602(20):5375-5389. PubMed ID: 39316014 [TBL] [Abstract][Full Text] [Related]
18. Group III/IV muscle afferents impair limb blood in patients with chronic heart failure. Amann M; Venturelli M; Ives SJ; Morgan DE; Gmelch B; Witman MA; Jonathan Groot H; Walter Wray D; Stehlik J; Richardson RS Int J Cardiol; 2014 Jun; 174(2):368-75. PubMed ID: 24794967 [TBL] [Abstract][Full Text] [Related]
19. Type III-IV muscle afferents are not required for steady-state exercise hyperpnea in healthy subjects and patients with COPD or heart failure. Poon CS; Song G Respir Physiol Neurobiol; 2015 Sep; 216():78-85. PubMed ID: 25911558 [TBL] [Abstract][Full Text] [Related]
20. Intrathecal fentanyl blockade of afferent neural feedback from skeletal muscle during exercise in heart failure patients: Influence on circulatory power and pulmonary vascular capacitance. Van Iterson EH; Snyder EM; Joyner MJ; Johnson BD; Olson TP Int J Cardiol; 2015 Dec; 201():384-93. PubMed ID: 26310984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]